`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`:
`:
`:
`:
`:
`:
`:
`:
`
`CIVIL ACTION
`
`NO. 22-252
`
`ARBUTUS BIOPHARMA CORPORATION
`and GENEVANT SCIENCES GMBH,
`
`
`
`
`
`
`
`
`
`
`
`
`Plaintiffs,
`
`
`
`
`
`
`
`
`
`
`v.
`
`
`
`
`
`
`
`
`
`
`
`MODERNA, INC. and MODERNATX, INC.,
`
`
`
`
`
`
`
`
`
`ORDER
`
`AND NOW, this 12th day of October, 2023, upon consideration of Plaintiffs’ September 27,
`
`
`
`2023 discovery dispute letter (D.I. 133) and Defendant’s Response (D.I. 134), and following a
`
`conference, it is hereby ORDERED that:
`
`1. Plaintiffs’ request for the production of documents and ESI from Moderna, Inc.’s CEO Stephane
`
`Bançel is DENIED WITHOUT PREJUDICE. Plaintiffs may, if necessary, re-raise this request
`
`at a later date.
`
`2. Plaintiffs’ request for the production of documents produced by Defendant in the Moderna, Inc. v.
`
`Pfizer, Inc. litigation is DENIED WITHOUT PREJUDICE. Plaintiffs shall submit to Defendant
`
`requests for specific categories of documents from that litigation, and thereafter, counsel shall meet
`
`and confer regarding production of those categories of documents.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`BY THE COURT:
`
`
`
`/s/ Mitchell S. Goldberg
`MITCHELL S. GOLDBERG, J.
`
`
`
`